Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Amnion Stories

2013-11-26 12:27:16

STUDIES DEMONSTRATE STRONG HEALING RESULTS OF EPIFIX® AND AMNIOFIX® MARIETTA, Ga., Nov. 26, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today the summaries of a selection of the seven posters highlighting MiMedx allografts presented at the recent 10(th) Annual Desert Foot High Risk Diabetic Foot Conference in Phoenix,...

2013-10-03 16:23:30

EpiFix® is the subject of six poster abstracts accepted at SAWC MARIETTA, Ga., Oct. 3, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that a poster detailing an EpiFix® case study received the award for the highest scoring abstract in the case study category at the recent Symposium on Advanced Wound Care ("SAWC")....

2013-07-31 08:26:46

MARIETTA, Ga., July 31, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its study "Biological Properties of Dehydrated Human Amnion/Chorion Grafts: Implications for Chronic Wound Healing" has been accepted for publication in the International Wound Journal. The electronic publication of the study will be...

2013-06-11 12:29:46

MARIETTA, Ga., June 11, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of three newly issued patents related to tissue allografts derived from the placenta. The U.S Patent Office has issued to MiMedx® U.S. Patent Number 8,409,626, "Placental Tissue Grafts" with a grant date of April 2, 2013. The U.S....

2009-11-23 15:15:49

For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought. Reporting in Oncogene, a publication of Nature Publishing Group, the research teams of Anthony Atala, M.D., director of the Wake Forest Institute for Regenerative Medicine, and Markus Hengstchläger, Ph.D.,...

2005-08-05 08:31:23

By Maggie Fox, Health and Science Correspondent WASHINGTON (Reuters) - Scientists looking for easier and less-controversial alternatives to stem cells from human embryos said on Friday they found a potential source in placentas saved during childbirth. They described primitive cells found in a part of the placenta called the amnion, which they coaxed into forming a variety of cell types and which look very similar to sought-after embryonic stem cells. With 4 million children born in the...

2005-08-05 08:24:59

By Maggie Fox, Health and Science Correspondent WASHINGTON (Reuters) - Scientists looking for easier and less-controversial alternatives to stem cells from human embryos said on Friday they found a potential source in placentas saved during childbirth. They described primitive cells found in a part of the placenta called the amnion, which they coaxed into forming a variety of cell types and which look very similar to sought-after embryonic stem cells. With 4 million children born in the...